Related references
Note: Only part of the references are listed.Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt
Yohei Watanabe et al.
PLOS PATHOGENS (2011)
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir
M. A. Rameix-Welti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR
Mingyue Zheng et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
The evolution of H5N1 influenza viruses in ducks in southern China
H Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR
Y Guan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia
YJ Guo et al.
VIROLOGY (2000)